FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 124 filers reported holding FIVE PRIME THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 1.83 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $20,438,000 | -10.0% | 542,548 | -59.4% | 0.02% | 0.0% |
Q4 2020 | $22,706,000 | +184.8% | 1,334,848 | -21.3% | 0.02% | +212.5% |
Q3 2020 | $7,972,000 | -25.1% | 1,696,186 | -2.7% | 0.01% | -11.1% |
Q2 2020 | $10,639,000 | +137.7% | 1,744,048 | -11.6% | 0.01% | +125.0% |
Q1 2020 | $4,476,000 | -44.7% | 1,971,917 | +11.9% | 0.00% | -33.3% |
Q4 2019 | $8,087,000 | +56.3% | 1,761,971 | +32.0% | 0.01% | +50.0% |
Q3 2019 | $5,173,000 | -25.4% | 1,334,891 | +16.2% | 0.00% | -33.3% |
Q2 2019 | $6,930,000 | -16.1% | 1,149,200 | +86.5% | 0.01% | -25.0% |
Q1 2019 | $8,256,000 | +83.5% | 616,100 | +27.4% | 0.01% | +60.0% |
Q4 2018 | $4,498,000 | +115.4% | 483,705 | +222.5% | 0.01% | +150.0% |
Q3 2018 | $2,088,000 | -78.9% | 150,000 | -74.7% | 0.00% | -60.0% |
Q2 2018 | $9,881,000 | +55.8% | 593,000 | +60.6% | 0.01% | -28.6% |
Q1 2018 | $6,343,000 | +119.3% | 369,200 | +422.2% | 0.01% | +133.3% |
Q3 2017 | $2,892,000 | -77.7% | 70,700 | -83.6% | 0.00% | -82.4% |
Q2 2017 | $12,992,000 | -22.4% | 431,500 | -6.8% | 0.02% | -26.1% |
Q1 2017 | $16,734,000 | +516.6% | 462,901 | +795.4% | 0.02% | +360.0% |
Q3 2016 | $2,714,000 | -45.9% | 51,700 | -57.4% | 0.01% | -50.0% |
Q2 2016 | $5,016,000 | -47.1% | 121,300 | -48.0% | 0.01% | -44.4% |
Q1 2016 | $9,479,000 | -27.1% | 233,300 | -25.5% | 0.02% | -35.7% |
Q4 2015 | $12,998,000 | +2596.7% | 313,200 | +900.6% | 0.03% | +2700.0% |
Q3 2015 | $482,000 | -88.2% | 31,300 | -81.0% | 0.00% | -88.9% |
Q2 2015 | $4,089,000 | +25.0% | 164,600 | +14.9% | 0.01% | +28.6% |
Q1 2015 | $3,272,000 | – | 143,200 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|